Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ONO-4685 by Ono Pharmaceutical for Follicular Lymphoma: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase...
ONO-4685 by Ono Pharmaceutical for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Plaque Psoriasis (Psoriasis Vulgaris). According to...
ONO-4685 by Ono Pharmaceutical for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According to...
ONO-4685 by Ono Pharmaceutical for Mycosis Fungoides: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Mycosis Fungoides. According to GlobalData, Phase...
ONO-4685 by Ono Pharmaceutical for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy. According...
ONO-4685 by Ono Pharmaceutical for Sezary Syndrome: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Sezary Syndrome. According to GlobalData, Phase...
ONO-4685 by Ono Pharmaceutical for Cutaneous T-Cell Lymphoma: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Cutaneous T-Cell Lymphoma. According to GlobalData,...
ONO-4685 by Ono Pharmaceutical for T-Cell Lymphomas: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for T-Cell Lymphomas. According to GlobalData, Phase...